Emerging Antifungal Targets and Strategies
Open accessThe DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Abstract
Despite abundant research in the field of antifungal drug discovery, fungal infections remain a significant healthcare burden. There is an emerging need for the development of novel antifungals since those currently available are limited and do not completely provide safe and secure protection. Since the current knowledge regarding the physiology of fungal cells and the infection mechanisms is greater than ever, we have the opportunity to use this for the development of novel generations of antifungals. In this review, we selected and summarized recent studies describing agents employing different antifungal mechanisms. These mechanisms include interference with fungal resistance, including impact on the efflux pumps and heat shock protein 90. Additionally, interference with virulence factors, such as biofilms and hyphae; the impact on fungal enzymes, metabolism, mitochondria, and cell wall; and antifungal vaccines are explored. The agents investigated belong to different classes of natural or synthetic molecules with significant attention given also to plant extracts. The efficacy of these antifungals has been studied mainly in vitro with some in vivo, and clinical studies are needed. Nevertheless, there is a large quantity of products employing novel antifungal mechanisms that can be further explored for the development of new generation of antifungals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was synthesized based on ToAP2 and exhibited antifungal activity against Sporothrix globosa with good serum stability and low toxicity (81).”
From Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review (2023) · cites this paper as [81]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Cell wall of fungus, being the outermost component of the cell, facilitates the initial physical interaction between microorganisms and their environment, including the host [19].”
From Mitochondrial anchor protein Num11 is key to pathogenicity of Candida albicans by affecting mitochondrial function and cell wall masking (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resistance of Candida to azoles and echinocandins worldwide
Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706 · cited 1×
“The exact mechanism of resistance is linked with the mutation of two regions of the FKS1p subunit of β-(1,3) d-glucan synthase, which subsequently leads to the substitution of serine 645 for proline, phenylalanine, and tyrosine and changes the echinocandins target site [40].”
BackgroundStone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs · doi:10.1007/s40265-016-0538-7 · Cited by 537 · cited 2×
“However, due to recorded significant dose-limiting toxicity of this formulation, mainly nephrotoxicity and infusion-related reactions, less toxic formulations were developed [27].”
BackgroundAmphotericin forms an extramembranous and fungicidal sterol sponge
Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., Wang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1496 · Cited by 528 · cited 2×
“It is proposed that extraction of the essential cell lipid underlies the antifungal action of this compound [26].”
BackgroundCampoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 416 · cited 1×
“Mechanisms of antifungal resistance include decrease of effective drug concentration, drug target alterations, and metabolic bypasses [48].”
BackgroundSpampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411 · cited 1×
“Additionally, point mutations in ERG3 can inactivate C5 sterol desaturase leading to alterations in the ergosterol synthetic pathway and inducing azole resistance [15].”
BackgroundCavassin, F. B., Baú-Carneiro, J. L., Vilas-Boas, R. R., & Queiroz-Telles, F. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00382-7 · Cited by 382
Lemke, A., Kiderlen, A. F., & Kayser, O. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1955-9 · Cited by 305
Candida Species Biofilms’ Antifungal Resistance
Silva, S., Rodrigues, C., Araújo, D., Rodrigues, M., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 302
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03470-14 · Cited by 294 · cited 1×
“Mutations in ERG11 are frequent among azole-resistant clinical fungal strains [103].”
Background
Cited by
Yassin, M. T., Mostafa, A. A.-F., Al-Askar, A. A., & Al-Otibi, F. O. (2022) · Crystals · doi:10.3390/cryst12060774 · Cited by 100
Recent Advances in the Allergic Cross-Reactivity between Fungi and Foods
Xing, H., Wang, J., Sun, Y., & Wang, H. (2022) · Journal of Immunology Research · doi:10.1155/2022/7583400 · Cited by 92
Zhang, C.-W., Zhong, X., Zhao, Y.-S., Rajoka, M. S. R., Hashmi, M. H., Zhai, P. C., & Song, X. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100262 · Cited by 73
Fish Skin Mucus Extracts: An Underexplored Source of Antimicrobial Agents
Díaz‐Puertas, R., Adamek, M., Mallavia, R. M., & Falcó, A. (2023) · Marine Drugs · doi:10.3390/md21060350 · Cited by 60
“This situation is substantially worsened by the long-lasting drought (with a few recent exceptions [4]) in the discovery of new classes of antibiotics since 1962 [1,5] and the continued scarcity and specificity of antifungals [6] and antivirals [7].”
BackgroundInfluentialRecent drug development and treatments for fungal infections
Roy, M., Karhana, S., Shamsuzzaman, M., & Khan, M. A. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-00999-z · Cited by 51
“Terbinafine, when applied topically, causes adverse events like gastrointestinal disturbance, erythema, urticaria, rashes, neutropenia, and musculoskeletal reactions [46].”
BackgroundMaione, A., Pietra, A. L., de Alteriis, E., Mileo, A., Falco, M. D., Guida, M., & Galdiero, E. (2022) · Microorganisms · doi:10.3390/microorganisms10091773 · Cited by 46
“From a clinical point of view, the formation of mixed biofilms leads to negative consequences for health, being reservoirs of microorganisms and having extremely different properties from planktonic populations, especially a high resistance to numerous antimicrobial agents [28].”
BackgroundMethodKumari, S., Alsaidan, O. A., Mohanty, D., Zafar, A., Das, S., Gupta, J. K., & Khalid, M. (2023) · Gels · doi:10.3390/gels9080626 · Cited by 52
“The antifungal agents that are now on the market block the formation of ergosterol (the most plentiful sterol in fungal cell membranes) into fungi and inhibited the growth or multiplication of cell membranes [5].”
BackgroundFusarium-Derived Secondary Metabolites with Antimicrobial Effects
Xu, M., Huang, Z., Zhu, W., Liu, Y., Bai, X., & Zhang, H. (2023) · Molecules · doi:10.3390/molecules28083424 · Cited by 42
Kamel, E. M., Abdelrheem, D. A., Salah, B., & Lamsabhi, A. M. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110372 · Cited by 42
Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review
Qin, Y., Wang, J., Lv, Q., & Han, B. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00003-23 · Cited by 38
“It was synthesized based on ToAP2 and exhibited antifungal activity against Sporothrix globosa with good serum stability and low toxicity (81).”
Yassin, M. T., Mostafa, A. A.-F., Al-Askar, A. A., & Al-Otibi, F. O. (2022) · Crystals · doi:10.3390/cryst12060816 · Cited by 40
The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
de Souza, C. M., Bezerra, B. T., Mellon, D. A., & de Oliveira, H. C. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100341 · Cited by 53
Niño‐Vega, G. A., Padró-Villegas, L., & López-Romero, E. (2024) · Journal of Fungi · doi:10.3390/jof10120871 · Cited by 40
Liang, X., Chen, D., Wang, J., Liao, B., Shen, J., Ye, X., Wang, Z., Zhu, C., Gou, L., Zhou, X., et al. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00245-0 · Cited by 32
“39,40 43 There are three major types of antifungal drugs in clinical, including azoles, polyenes and echinocandins.”
BackgroundEmerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations
Mijaljica, D., Spada, F., & Harrison, I. P. (2022) · Journal of Fungi · doi:10.3390/jof8080812 · Cited by 38
“Allylamines, including terbinafine (Figure 3), naftifine, butenafine and amorolfine [22,66], are a relatively new class of ergosterol biosynthesis inhibitors [60].”
BackgroundInfluentialRegidor, P. A., Thamkhantho, M., Chayachinda, C., & Palacios, S. (2023) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2023.2195001 · Cited by 31
“Miconazole is a synthetic imidazole derivative that has built a reputation for fast fungicidal action when being used topically against a wide variety of yeasts and dermatophytes (Sawyer et al. 1975, Ivanov et al. 2022).”
BackgroundEsmaeili, A., Saleh, I., & Abu‐Dieyeh, M. H. (2025) · Phytochemistry Reviews · doi:10.1007/s11101-025-10093-x · Cited by 39
“…species like isolates of C. glabrata (Ksiezopolska et al. 2021; Merdan et al. 2022; Murphy and Bicanic 2021) and C. auris (Fisher et al. 2018; Ivanov et al. 2022; Murphy and Bicanic 2021), and challenges related to antifungal drugs such as their limited antifungal range, toxicity, and high…”
InfluentialHesperetin—Between the Ability to Diminish Mono- and Polymicrobial Biofilms and Toxicity
Carević, T., Kostić, M., Nikolić, B., Stojković, D. S., Sokóvić, M., & Ivanov, M. (2022) · Molecules · doi:10.3390/molecules27206806 · Cited by 31
“Bearing in mind side effects and limitations of current antifungal pallet and an emerging demand for the development of novel antifungal therapeutics [9], anticandidal potential of hesperetin should be further explored, and has the potential to be utilized for the design of novel antifungal strategies.”
BackgroundSelf-citationBai, Y.-B., Zhang, M., Li, D., Zhao, Y., Huang, L., & Gao, J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c09037 · Cited by 29
Argüelles, J. C., Sánchez-Fresneda, R., Argüelles, A., & Solano, F. (2024) · Journal of Fungi · doi:10.3390/jof10050334 · Cited by 33
“Three main families of antifungals are currently available: polyenes, azoles, and echinocandins [8,11,12].”
BackgroundMetal Nanomaterials and Hydrolytic Enzyme-Based Formulations for Improved Antifungal Activity
Lyagin, I., Aslanli, A., Domnin, M., Stepanov, N., Senko, O. V., Maslova, O. V., & Efremenko, E. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411359 · Cited by 27
Antifungal metabolites, their novel sources, and targets to combat drug resistance
Choudhary, M., Kumar, V., Naik, B., Verma, A., Saris, P. E. J., Kumar, V., & Gupta, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1061603 · Cited by 25
Korpayev, S., Zengin, G., Ak, G., Glamočlija, J., Sokóvić, M., Aničić, N., Gašić, U. M., Stojković, D. S., Agamyradov, M., Çetiz, M. V., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4663 · Cited by 23
“In search of new antifungal agents (Ivanov, Ćirić, and Stojković 2022) effective to fight against more and more resistant microfungi it is crucial to discover new sources from plants.”
Self-citationRadwan, I. T., El-sherbiny, I. M., & Metwally, N. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-63149-x · Cited by 23
Bravo-Chaucanés, C. P., Vargas‐Casanova, Y., Chitiva, L. C., Ceballos-Garzón, A., Costa, G. M., & Parra‐Giraldo, C. M. (2022) · Journal of Fungi · doi:10.3390/jof8080784 · Cited by 26
Amorim, C. F., Iglesias, B. A., Pinheiro, T. D. R., Lacerda, L. E., Sokolonski, A. R., Pedreira, B. O., Moreira, K. S., Burgo, T. A. L., Meyer, R., Azevedo, V., et al. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103343 · Cited by 23
Pfaller, M. A., Carvalhaes, C. G., & Castanheira, M. (2023) · Mycoses · doi:10.1111/myc.13620 · Cited by 22
Antifungal Effect of Polymethyl Methacrylate Resin Base with Embedded Au Nanoparticles
Marić, I., Zore, A., Rojko, F., Škapin, A. S., Štukelj, R., Učakar, A., Vidrih, R., Veselinović, V., Gotić, M., & Bohinc, K. (2023) · Nanomaterials · doi:10.3390/nano13142128 · Cited by 19
“It is necessary to take advantage of the current rich knowledge about the fungal cell’s physiology and the mechanisms of infection and use the knowledge resources for the development of new generations of antifungal drugs [29].”
BackgroundCarbon Nanotube Hybrid Materials: Efficient and Pertinent Platforms for Antifungal Drug Delivery
Chandra, D. K., Reis, R. L., Kundu, S. C., Kumar, A., & Mahapatra, C. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202301044 · Cited by 20
Chand, P., Narula, K., Radhakrishnan, V. S., Sharma, S., Kumari, S., Mondal, N., Singh, S. P., Mishra, P., & Prasad, T. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00562 · Cited by 21
Modern Strategies of Drug Therapy: Multi-Target Drug Delivery, Bioimaging, Diagnostics
Fedorova, O. V., Ovchinnikova, I. G., Rusinov, G. L., Avdeeva, V. V., Zhdanov, А. P., Zhizhin, K. Y., Kuznetsov, N. T., Zakharova, L. Y., Kuznetsova, D. A., Razuvayeva, Y. S., et al. (2025) · Russian Journal of General Chemistry · doi:10.1134/s1070363225606726 · Cited by 18
Chaiwut, C., Tadtong, S., Akachaipaibul, P., Jiaranaikulwanitch, J., Singh, S. K., Okonogi, S., Syukri, D. M., & Chittasupho, C. (2024) · Gels · doi:10.3390/gels11010013 · Cited by 16
Recent research frontiers of heterocycles as antifungal Agents: Insights from the past five years
Tahlan, S., Singh, S., Dey, H., Kaira, M., & Pandey, K. C. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117801 · Cited by 15
Salih, E. Y. A., Julkunen‐Tiitto, R., Luukkanen, O., & Fyhrqvist, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112469 · Cited by 16
“[89] and Aboody and Mickymaray [7] found that extracts containing apigenin inhibit biofilm formation in C.”
BackgroundResearch advances and public health strategies in China on WHO priority fungal pathogens
Wang, Y., Han, L., Gong, J., Liu, L., Miao, B., & Xu, J. (2025) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2025.2561612 · Cited by 15
Sun, Y., Zhang, J., Liu, R., Gao, Z., Wu, X., Liu, N., Zhang, H., Li, K., Luo, Z., Liu, R., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116949 · Cited by 14
Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects
Galgóczy, L. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.5c00103 · Cited by 17
“71 Several promising candidate molecules possessing novel antifungal mechanisms of action have already reached various stages of clinical testing.”
Ergüden, B., Lüleci, H. B., & Ünver, Y. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03584-y · Cited by 13
Fu, C. M., Wan, S., Yang, P., Zhao, X., Yan, Y., Jiang, S., & Ali, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1419436 · Cited by 12
“…of cellular protein synthesis and control life activities indirectly, and any changes leading to ribosomal component alterations can directly affect the normal function of ribosomes; thus, ribosomes are a common target of antifungal agents (Hurtado-Rios et al., 2022; Ivanov et al., 2022).”
BackgroundRole of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases
Nithyasree, V., Magdalene, P., Kumar, P., Preethi, J., & Gromiha, M. M. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01251-1 · Cited by 12
Helal, D. A., Osama, A. A., El-Nabarawi, M. A., Teaima, M. H. M., & Al-Samadi, I. E. I. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125193 · Cited by 12
Zhao, T., Sun, Y., Meng, Y., Liu, L., Dai, J., Yan, G., Pan, X., Guan, X., Song, L., & Lin, R. (2023) · Molecules · doi:10.3390/molecules28176279 · Cited by 12
Various Biomimetics, Including Peptides as Antifungals
Efremenko, E. N., Aslanli, A., Stepanov, N., Senko, O. V., & Maslova, O. V. (2023) · Biomimetics · doi:10.3390/biomimetics8070513 · Cited by 12
“Despite the great interest in biomimetics that causes the death of fungal cells, there remains a general problem with their practical application, which is associated with the need for their toxicity to other eukaryotic cells [94].”
BackgroundAntibacterial and Antifungal Potential of Plant Secondary Metabolites
Šovljanski, O., Cvetanović, A. D., & Tomić, A. (2023) · Reference series in phytochemistry · doi:10.1007/978-3-031-30037-0_6-1 · Cited by 11
Guo, L., Zheng, L., Dong, Y., Wang, C., Deng, H., Wang, Z., & Xu, Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1392564 · Cited by 10
“Miconazole (MCZ) is a synthetic imidazole derivative that has potent antifungal ef fi cacy when being used topically against a wide variety of yeasts and dermatophytes (Sawyer et al., 1975; Ivanov et al., 2022).”
BackgroundUšjak, L. J., Stojković, D. S., Carević, T., Milutinović, V. M., Sokóvić, M., Niketić, M. S., & Petrović, S. (2024) · Antibiotics · doi:10.3390/antibiotics13010041 · Cited by 11
“In an era of growing antimicrobial resistance, it is crucial to discover new antibacterial and antifungal agents [1,2].”
BackgroundSelf-citationArgüelles, A., Sánchez-Fresneda, R., Guirao-Abad, J. P., Lozano, J. A., Solano, F., & Argüelles, J. C. (2023) · Journal of Fungi · doi:10.3390/jof9040442 · Cited by 10
Pale-Ezquivel, I., Sánchez‐Velásquez, L. R., Jiménez-Escobar, M. P., Mendoza-López, M. R., Musule, R., Alarcón-Gutiérrez, E., Pineda‐López, M. D. R., Pascual-Pineda, L. A., & Domínguez, Z. (2024) · Industrial Crops and Products · doi:10.1016/j.indcrop.2024.119824 · Cited by 10
Inukai, T., Chen, P., Kokuba, H., Cabral, H., & Nakamura, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106073 · Cited by 9
Salem, M. Z. M., Hassan, A. G. A., Amer, A., Abdullah, M. F. G., Ahmed, S. M. A., Mahmoud, M. M., Philip, B., & Behiry, S. I. (2025) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-025-06651-0 · Cited by 10
“Flavonoids have a significant antifungal activity effect; their exact mechanisms of action are still being investigated [79, 80].”
Jarungsirawat, R., Kajthunyakarn, W., Siriwachirachai, C., & Pongjanyakul, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081723 · Cited by 9
“It is active against a broad spectrum of yeast and other fungal pathogens and is available for oral and parenteral uses [7].”
BackgroundImpact of the host microbiota on fungal infections: New possibilities for intervention?
Chow, E. W. L., Pang, L. M., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114896 · Cited by 11
Alternative and Classical Processes for Disinfection of Water Polluted by Fungi: A Systematic Review
Caicedo-Bejarano, L. D., Morante-Caicedo, A., Narváez, S. P. C., & Serna-Galvis, E. A. (2024) · Water · doi:10.3390/w16070936 · Cited by 11
“It has been established that the chlorine species (i.e., Cl 2 , HOCl, and OCl − ) in aqueous samples can oxidize organic and inorganic matter and inactivate pathogens (e.g., fungi and bacteria).”
BackgroundSynthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety
Hao, Y., Wang, R., Ni, T., Monk, B. C., Tyndall, J. D. A., Bao, J., Wang, M., Chi, X., Yu, S., Jin, Y., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116637 · Cited by 9
Chauhan, V., Kumar, A., Tripathi, S., Jha, M., Kumar, N., Poluri, K. M., & Gupta, P. (2024) · Discover Public Health · doi:10.1186/s12982-024-00274-y · Cited by 11
Kayıran, S. D., TAVLI, Ö. F., Kara, E. M., Kaplan, A., Şahin, H., Boğa, M., & Özkan, E. E. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1618761 · Cited by 7
Natural product based approaches to overcome Candida glabrata and emerging AMR threats
Sahu, B. K., Patra, S. K., Sahu, M. C., & Panda, S. K. (2026) · Frontiers in Antibiotics · doi:10.3389/frabi.2026.1767032 · Cited by 7
“…in terpenoids as antifungal or antifungal-adjuvant agents against C. glabrata , particularly due to their capacity to penetrate bio fi lms and circumvent resistance mechanisms such as ef fl ux pump overexpression and alterations in ergosterol biosynthesis (Haque et al., 2016; Ivanov et al., 2022).”
Antifungal Potential of Carnosic Acid from Salvia somalensis against Phytopathogenic Fungi
Iobbi, V., Vetere, M. L., Lanteri, A. P., Reinhardt, J. K., Danton, O., Keller, M., Hamburger, M. O., Salis, A., Damonte, G., Potterat, O., et al. (2024) · Agronomy · doi:10.3390/agronomy14071444 · Cited by 7
“New compounds to replace those that have become unavailable due to toxicity or resistance in target pathogens are urgently needed [96–98].”
Genet, A., & Girma, A. (2024) · Universa Medicina · doi:10.18051/univmed.2024.v43.102-113 · Cited by 6
“(39) However, beyond the side effects, it is common to see resistance to one or more of the above clinically prescribed antifungal drugs using different survival strategies, viz.”
BackgroundAction Mechanisms of Medicinal Plant Components as Antimycosis: A Literature Review
El‐Sakhawy, M., Abusalim, G. S., Ashour, A. A., & Balah, M. A. A. (2025) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt20251647 · Cited by 6
Maione, A., Imparato, M., Galdiero, M., de Alteriis, E., Feola, A., Galdiero, E., & Guida, M. (2023) · Antibiotics · doi:10.3390/antibiotics12071210 · Cited by 6
“qRT-PCR Analysis Cells of biofilm grown together with β-escin (5 μg mL−1) at 37 ◦C for 24 h were scraped and washed in PBS as previously reported [37].”
MethodRan, Y., Shehzadi, K., Liang, J., & Yu, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063512 · Cited by 7
Khan, M. S. (2024) · Annals of African Medicine · doi:10.4103/aam.aam_197_23 · Cited by 6
“[32] In the clinical settings, echinocandins (targeting cell wall) have been combined with azoles (targeting cell membrane) for better efficacy against fungal infections.”
Nanoemulsions of plant-based bioactive compounds with antimicrobial applications: a review
Prado, J. C. S., Prado, G. M., de Aguiar, F. L. L., Neves, A. M., do Nascimento, J. F., Abreu, F. O. M. D. S., & Fontenelle, R. O. D. S. (2024) · Ciência e Natura · doi:10.5902/2179460x74325 · Cited by 10
Molecular Targeting and Novel Therapeutic Approaches against Fungal Infections
Kumar, A., Bansal, P., Katiyar, D., Prakash, G. K. S., & Rao, N. G. R. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230302123310 · Cited by 5
Recalcitrant cutaneous fungal infections—A growing problem
Koh, X. Q., & Pan, J. Y. (2023) · Australasian Journal of Dermatology · doi:10.1111/ajd.14115 · Cited by 6
Yang, G., Niu, X., Zhuang, T., Zhu, X., Xu, Q., Wang, H., Shao, J., Wang, C., Yang, Y., Wang, T., et al. (2025) · Virulence · doi:10.1080/21505594.2025.2519149 · Cited by 4
“The respiratory chain has been proposed as an attractive target for developing antifungal agents to alleviate fungal infections and prevent the evolution of drug resistance [19].”
Inhibitory effect of copper chelators on the budding in Candida albicans
Futamura, Y., Yamamoto, K., Uson‐Lopez, R. A., Aono, H., Shimizu, T., Hori, Y., Kino, K., & Osada, H. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00033-25 · Cited by 4
Tuấn, Đ. A. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107763 · Cited by 5
Ivanov, M., Petrović, J. D., Carević, T., Gašić, U. M., Milinčić, D. D., Pešić, M. B., & Ćirić, A. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.11.009 · Cited by 4
Self-citationValderrama, V., Sanchéz-Sáez, P., Delso, M., Díaz‐Dosque, M., Escobar, A. F., Budini, M., Catalán, M., Vivar, R., López‐Muñoz, R., Jara, J. A., et al. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad316 · Cited by 4
Current Updates on Pathogenesis, Systemic Therapy, and Treatment of Invasive Fungal Infections
Singh, S. K., & Pancholi, S. S. (2024) · Current Drug Targets · doi:10.2174/0113894501337502241015121015 · Cited by 5
Ivanov, M., Aleksandrov, A. P., Božunović, J., Días, M. I., Calhelha, R. C., Kulaš, J. B., Barros, L., Ferreira, I. C. F. R., & Stojković, D. S. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01769-z · Cited by 4
“The emerging need for novel therapeutics to address a range of illnesses and conditions such as infections (Ivanov et al. 2022) and inflammations (Attiq et al. 2018) underscores the urgency for innovative approaches in drug development.”
Self-citationSowmya, T. N., Gurudatt, D. M., & Raveesha, K. A. (2025) · Molecules · doi:10.3390/molecules30173595 · Cited by 4
“This property may be due to the increased solubility and amphiphilicity of glycosylated plant metabolites, which enhance their membrane transport [49].”
Synthesis, in vitro antimicrobial activity, and in silico studies of 1-aminoalkyl-2-naphthols
Beyene, F., Mazumder, A., Tadesse, S., Asres, K., & Bisrat, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-23064-1 · Cited by 4
Nociceptive TRP channels function as molecular target for several antifungal drugs
Okabe, S., Takahashi, K., Hashimoto, M., & Ohta, T. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.13039 · Cited by 4
“However, topical antifungals can cause pain, itching, burning sensation, and erythema [4 – 6] through unclear mechanisms.”
Construction and activity evaluation of novel CHS inhibitors against fungal infections
Yu, S., Zhang, S., Zhang, A., Han, H., Han, J., & Sun, B. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117337 · Cited by 4
Polypeptides Targeting Paracoccidioides brasiliensis Drk1
Marcos, C. M., de Oliveira, H. C., Assato, P. A., Oliveira, L. T., Fregonezi, N. F., dos Santos, K. S., Costa-Orlandi, C. B., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2023) · Journal of Fungi · doi:10.3390/jof9100980 · Cited by 4
“…are being explored, including drug repurposing initiatives [8] and natural or synthetic compounds tailored to targets encompassing distinct facets of the cell wall and membrane architecture, metabolic pathways, signal transduction cascades, gene expression modulation, and virulence factors [9–12].”
Evaluating the Impact of Antifungal Drugs on Human Health and Exploring Alternative Treatments
Mandal, D. (2024) · Oriental Journal Of Chemistry · doi:10.13005/ojc/400302 · Cited by 4
Fakhim, H., Vaezi, A., Morovati, H., Bandegani, A., Abbasi, K., Emami, S., Nasiry, D., Hashemi, S. M., Ahangarkani, F., & Badali, H. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101437 · Cited by 3
An Update on Human Fungal Diseases: A Holistic Overview
Singh, S., Vijayaraghavan, P., Devi, S., & Hameed, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_1 · Cited by 3
Anti-virulence and anti-efflux pump activity of synthetic defensins and histatin in Candida auris
Shaban, S., Patel, M., & Ahmad, A. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107644 · Cited by 3
Potential of Streptomycetes as Biocontrol and Plant Growth-Promoting Agents
El-Shatoury, S. A., & Diab, M. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-5803-2_5 · Cited by 4
Approach for Development of Topical Ketoconazole-Loaded Microemulsions and Its Antifungal Activity
Naksuriya, O., Nitthikan, N., Supadej, K., Kheawfu, K., Khonkarn, R., Ampasavate, C., Intasai, N., Monton, C., & Kiattisin, K. (2023) · Trends in Sciences · doi:10.48048/tis.2023.7046 · Cited by 3
Gao, Z., Zhang, J., Li, K., Sun, Y., Wu, X., Zhang, G., Liu, R., Liu, R., Zhao, D., & Cheng, M. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00589e · Cited by 3
Antifungal activity of microbial secondary metabolites
Bodade, R. G., & Lonkar, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23950-2.00005-9 · Cited by 3
Current Perspectives on Antifungal Resistance: Focus on Opportunistic Mycoses
Muñoz, N. R. A., & Flores, C. F. Y. (2024) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt20241064 · Cited by 3
Dosoky, N. S., Satyal, P., Sorensen, A., & Setzer, W. N. (2023) · Compounds · doi:10.3390/compounds3010012 · Cited by 3
Phytoconstituents and antidermatophytic activity of crude extracts of Senna occidentalis
Husseini, H. A., Olonitola, O. S., & Aliyu, M. S. (2023) · UMYU Journal of Microbiology Research (UJMR) · doi:10.47430/ujmr.2381.019 · Cited by 3
Antibacterial and Antifungal Potential of Plant Secondary Metabolites
Šovljanski, O., Cvetanović, A. D., & Tomić, A. (2025) · Reference series in phytochemistry · doi:10.1007/978-3-031-51158-5_6 · Cited by 3
Zalukhu, Z. K., & Widiyarti, S. H. (2025) · Jurnal Locus Penelitian dan Pengabdian · doi:10.58344/locus.v4i4.4080 · Cited by 3
Synthetic and Natural Antifungals—Desirable and Hazardous Effects
Stojković, D. S., Ivanov, M., & Ćirić, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179608 · Cited by 3
Self-citationInsights into phosphatidic acid phosphatase and its potential role as a therapeutic target
Carman, G. M., Stukey, G. J., Jog, R., & Han, G. (2025) · Advances in Biological Regulation · doi:10.1016/j.jbior.2025.101074 · Cited by 4
Caruso, G. R., Curtis, A., Kavanagh, K. A., & Kress, M. R. V. Z. (2025) · ACS Omega · doi:10.1021/acsomega.5c03275 · Cited by 2
“21,22 The activity of AgNPs depends not only on the target organism but also on their synthesis method and intrinsic properties.”
Faleye, O. O., Yunus, A., Lee, J., & Lee, J. (2025) · Biofilm · doi:10.1016/j.bioflm.2025.100319 · Cited by 2
Achilonu, C. (2026) · Drugs and Drug Candidates · doi:10.3390/ddc5030047 · Cited by 2
Antibacterial and Antifungal Materials
Hosseini, S. M., Moez, N. M., & Arabestani, M. R. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781837671540-00086 · Cited by 2
Du, X., Zhou, L., Li, Y., Zhang, F., Wang, L., Yao, J., Chen, X.-H., Liu, S. M., & Cao, Y. (2024) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13978 · Cited by 2
Sharif, M., Irfan, M., Kousar, K., Mamurova, A., Duarte‐Peña, L., Hernández‐Parra, H., Cortés, H., Peña‐Corona, S. I., Khan, K., Habtemariam, S., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03544-3 · Cited by 2
“Many contemporary anti-fungal medications primarily target ergosterols by inhibiting ergosterol synthesis or directly binding to ergosterols attached to the cytoplasmic membrane (Ivanov et al. 2022).”
Madzinga, M., Malefo, M. B. L., van der Merwe, C., Canha, M. N. D., Wadhwani, A., Lall, N., & Kritzinger, Q. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106596 · Cited by 2
Metadata
- Authors
- Ivanov, M., Ćirić, A., & Stojković, D.
- Affiliations
- University of Belgrade (RS)
- Corresponding author
- Ivanov, Marija
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-02
- Volume
- 23
- Issue
- 5
- Pages
- 2756
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8911111
- OpenAlex
- W4214877855
- Cited by
- 160
- References
- 154
- Citations by year
- 2026: 31 · 2025: 46 · 2024: 36 · 2023: 35 · 2022: 12
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministarstvo prosvete, nauke i tehnoloskog razvoja (451-03-9/2021–14/200007)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- antifungal drug discovery, antifungal drug targets, fungal infection, efflux pumps, HSP90, fungal virulence factors, biofilm, fungal hyphae, fungal enzymes, fungal metabolism, mitochondria, cell wall, antifungal vaccines, plant extracts, natural products, synthetic compounds, drug resistance
- MeSH terms
- Antifungal Agents, Cell Wall, Humans, Mycoses, Biofilms, Drug Resistance, Fungal, Hyphae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.